Human Papillomavirus Vaccine Update

Diane R Blake; Amy B Middleman

doi:10.1016/j.pcl.2016.11.003

Human Papillomavirus Vaccine Update

Pediatr Clin North Am. 2017 Apr;64(2):321-329. doi: 10.1016/j.pcl.2016.11.003.

Authors

Diane R Blake¹, Amy B Middleman²

Affiliations

¹ Department of Pediatrics, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01655, USA. Electronic address: diane.blake@umassmed.edu.
² Department of Pediatrics, University of Oklahoma Health Sciences Center, 1200 Children's Avenue, Suite 12200, Oklahoma City, OK 73104, USA.

PMID: 28292448
DOI: 10.1016/j.pcl.2016.11.003

Abstract

Rates of cancers attributable to human papillomavirus (HPV) are rising. A safe and extremely effective vaccine is available to prevent many of these cancers. Studies have shown that health care providers' recommendation to immunize is the most important factor in parents' decision. Parents of all adolescent boys and girls should receive a strong and unequivocal recommendation to vaccinate their child against HPV at the 11- or 12-year-old well child visit. Ideally, adolescents complete their HPV vaccine series by their 13th birthday, leading to greater immune response and protection before most adolescents are exposed to sexually transmitted HPV.

Keywords: Cervical cancer; Human papillomavirus; Oropharyngeal cancer; Vaccine.

Publication types

Review

MeSH terms

Adolescent
Attitude of Health Personnel
Child
Female
Humans
Male
Papillomavirus Infections / prevention & control*
Papillomavirus Vaccines / administration & dosage*
Parents / psychology*
Patient Acceptance of Health Care / psychology*
Professional-Patient Relations*
Uterine Cervical Neoplasms / prevention & control*

Substances

Papillomavirus Vaccines